Smoking and COVID-19: Increased Risk of Severe Complications

Jul.27.2022
Smoking and COVID-19: Increased Risk of Severe Complications
Smoking increases the risk of severe COVID-19 complications and death, according to a study by the American Heart Association.

A new study based on data from the American Heart Association's COVID-19 cardiovascular disease registry has revealed that individuals who smoked or vaped before being hospitalized with COVID-19 are more likely to experience severe complications and even death from SARS-CoV-2 infection compared to those who did not smoke or vape. These findings were published in the peer-reviewed open access scientific journal, PLOS ONE.


Researchers examined data from 107 registered hospitals nationwide on adults aged 18 years and above who were admitted for COVID-19 between January 2020 and March 2021. Smoking status was self-reported, and those who reported using traditional combustible cigarettes or e-cigarette products were classified as smokers without distinction between the two, and without information on smoking duration or previous smoking status. For final analysis, records of 4,086 individuals were selected, with a smoker to nonsmoker ratio of 1:2 (1,362 vs. 2,724), and with no statistical differences in terms of age, gender, race, medical history, or medication between the two groups.


A new study has shown that smoking or using e-cigarettes is linked to more severe cases of COVID-19, regardless of age, gender, race, or medical history.


According to a report, smokers have a 45% higher chance of dying compared to non-smokers, and a 39% higher chance of requiring mechanical ventilation.


While smoking is not related to medical history and drug use, it is a significant risk factor for death in individuals aged 18-59, as well as in Caucasian or obese individuals.


In general, individuals who smoke or use electronic cigarettes often have higher rates of other health conditions and risk factors that could impact how they are affected by COVID-19. However, our research has shown a significant increase in the risk of severe COVID-19, particularly among younger populations, regardless of medical history or drug use. This highlights the urgent need for widespread public health interventions such as anti-smoking campaigns and smoking cessation therapies, especially in the era of COVID-19. "These findings provide the most compelling evidence to date that smokers or users of electronic cigarettes are at higher risk of developing severe COVID-19 and dying from SARS-CoV-2 infection," said Dr. Aruni Bhatnagar, FAHA, senior author of the study and professor of medicine, biochemistry, and molecular biology at the University of Louisville School of Medicine.


Bhatnagar is a co-director of the Tobacco Regulatory Science Center at the American Heart Association, which is partially funded by the United States for this research. The research grants are from the National Institutes of Health and the Food and Drug Administration.


Sandeep R stated, "We established a COVID-19 CVD registry early in the pandemic to better understand the connection between COVID-19 and cardiovascular diseases, particularly in identifying increased risk, in order to provide information to diagnose and care for those at highest risk for complications.


The result of this study has achieved this goal and provided valuable information for individuals and their healthcare teams.


The American Heart Association launched a registry in 2020 to collect specific data on all COVID-19 hospitalized patients as part of the Get With The Guidelines® quality improvement program. All US hospitals caring for adults with active COVID-19 offer free registration and are equipped with infrastructure to support accurate data collection. Between 2020 and June 2022, over 160 hospitals provided data on more than 79,000 patient records.


I am an AI language model designed to generate human-like text. Could you please provide me with the specific text you want me to translate?


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

JTI Korea Introduces Ploom AURA With Four Heating Modes and Four Device Colors
JTI Korea Introduces Ploom AURA With Four Heating Modes and Four Device Colors
JTI Korea announced that its next-generation heated tobacco device Ploom AURA will officially launch in South Korea on April 14. The company held a media event on March 31 at the Fairmont Ambassador Seoul Hotel to unveil the product in Korea for the first time.
Apr.01 by 2FIRSTS.ai
2Firsts Data|China Vape Exports Sink to Three-Year April Low After Tax Rebate Ends, Falling to $694 Million
2Firsts Data|China Vape Exports Sink to Three-Year April Low After Tax Rebate Ends, Falling to $694 Million
China’s e-cigarette export value declined to $694 million in April 2026, marking the lowest April level in the past three years. The data is notable because April was the first full month after China removed export VAT rebates for certain e-cigarette products. Compared with April 2025, export value fell 20.9%; compared with April 2024, it was down 22.3%. Month-on-month, exports dropped 23.2% from March 2026.
Special Report
May.23
Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
Philippine Health Department Pushes Total Vape Ban, With Tobacco-Only Flavor Limit as Alternative
The Philippine Department of Health said it is pushing for a total ban on vape products. If a full ban is not feasible, DOH officer-in-charge Director Dr. Dominic Maddumba said vape products should at least be limited to plain tobacco flavors to reduce their appeal to minors.
May.06 by 2FIRSTS.ai
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
Capital Group Takes 5.61% Stake in KT&G, Joining Major Foreign Shareholders
KT&G disclosed in a regulatory filing on Friday that Capital Research and Management Company, the investment management arm of Capital Group, had acquired a 5.61% stake through purchases made on April 22 and May 4. The move places Capital Group among KT&G’s prominent foreign shareholders, alongside BlackRock, First Eagle Investment Management and Singapore’s sovereign wealth fund GIC.
May.08 by 2FIRSTS.ai
Product | 20ml E-liquid, Dual Modes with Up to 60,000 Puffs, Uwell Launches VALAYA AMP 60K Vape in the U.S.
Product | 20ml E-liquid, Dual Modes with Up to 60,000 Puffs, Uwell Launches VALAYA AMP 60K Vape in the U.S.
Uwell has recently launched its new disposable vape, the VALAYA AMP 60K, on its official website. The device features 20ml of pre-filled e-liquid and is rated for up to approximately 60,000 puffs. It is equipped with a 950mAh rechargeable battery and a 0.6Ω dual mesh coil. The product is now available through select online channels in the United States, with a listed price of $19.99.
Apr.09 by 2FIRSTS.ai
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s New Nicotine Rules Draw Cautious Optimism and Market Concerns, Local Tobacco Harm Reduction Advocate Says
Argentina’s new tobacco and nicotine framework marks a shift from prohibition toward registration, traceability and health surveillance. Argentine THR advocate Juan Facundo Teme told 2Firsts that adult consumers and parts of the local commercial sector are cautiously optimistic, but concerns remain over flavor limits, registration costs and market access. The policy’s implementation may determine whether Argentina can move informal sales into regulated channels.
May.11